Latest Advances in Lung Cancer Research

Tagrisso significantly improves survival in patients with unresectable stage III EGFR-mutated lung cancer, offering new hope for a longer life.

“Ground-glass opacity” on lung CT scans, a hazy sign of potential cancer, is linked to higher survival rates, emphasizing the importance of early detection.

Women’s lung cancer is often diagnosed late and treated less aggressively than men’s lung cancer, despite being the leading cause of cancer death among women.

Recent studies confirm genomic testing for NSCLC enhances treatment choices and survival, advocating for its standardization in clinical practice.

Study reveals 1 in 12 advanced lung cancer patients died from COVID-19 during the Omicron wave, highlighting the variant’s significant risk despite lower severity.

Study shows that smoking cessation was associated with a nearly 30% improvement in overall survival with lung cancer patients.

New research indicates lower income correlates with poorer lung cancer survival rates due to late diagnosis, with disparities influenced by socioeconomic status and systemic racism.

Canadian researchers developed IPRO, a deep learning model for lung cancer care, enhancing prognosis by analyzing pre-treatment CT scans without manual input.

A study developed and tested a remote intervention to improve the quality of life for lung cancer patients transitioning to post-treatment surveillance.

Research shows using both immunotherapy and chemotherapy for treatment doubles survival among those diagnosed with lung cancer.

Lung cancer in never smokers is becoming more prominent – especially in women. 12% of U.S. lung cancer patients are never-smokers and it is increasing.